T1	AdverseReaction 208 227	Glucose intolerance
T2	Factor 228 231	can
T3	Severity 265 277	irreversible
T4	AdverseReaction 499 525	hypersensitivity reactions
T5	Severity 485 490;497 498	Grade 4
T6	Severity 485 492	Grade 3
T7	AdverseReaction 889 901	Pancreatitis
T8	AdverseReaction 1521 1540	Glucose intolerance
T9	AdverseReaction 1670 1689	glucose intolerance
T10	Severity 1697 1709	irreversible
T11	AdverseReaction 1912 1929	thrombotic events
T12	Severity 1904 1911	Serious
T13	AdverseReaction 1941 1966	sagittal sinus thrombosis
T14	AdverseReaction 1971 1989	pulmonary embolism
T15	AdverseReaction 2090 2110;2116 2125	coagulation proteins decreased
T16	AdverseReaction 2116 2125;2221 2231	decreased fibrinogen
T17	AdverseReaction 2116 2125;2233 2251	decreased protein C activity
T18	AdverseReaction 2116 2125;2253 2271	decreased protein S activity
T19	AdverseReaction 2116 2125;2277 2294	decreased anti-thrombin III
T20	AdverseReaction 374 384	Thrombosis
T21	AdverseReaction 386 396	hemorrhage
T22	AdverseReaction 105 131	hypersensitivity reactions
T23	Severity 97 104	Serious
T24	AdverseReaction 143 154	anaphylaxis
T25	AdverseReaction 170 194	hemorrhagic pancreatitis
T26	AdverseReaction 182 194	pancreatitis
T27	Severity 160 166	Severe
E1	AdverseReaction:T1 Hypothetical:E2
E2	Factor:T2
E3	AdverseReaction:T1 Hypothetical:E2 Effect:E4
E4	Severity:T3
E5	AdverseReaction:T4 Effect:E6 Effect2:E7
E6	Severity:T5
E7	Severity:T6
E8	AdverseReaction:T7
E9	AdverseReaction:T8
E10	AdverseReaction:T9 Effect:E11
E11	Severity:T10
E12	AdverseReaction:T9
E13	AdverseReaction:T11 Effect:E14
E14	Severity:T12
E15	AdverseReaction:T13
E16	AdverseReaction:T14
E17	AdverseReaction:T15
E18	AdverseReaction:T16
E19	AdverseReaction:T17
E20	AdverseReaction:T18
E21	AdverseReaction:T19
E22	AdverseReaction:T20
E23	AdverseReaction:T21
E24	AdverseReaction:T22 Effect:E25
E25	Severity:T23
E26	AdverseReaction:T24
E27	AdverseReaction:T25
E28	AdverseReaction:T26 Effect:E29
E29	Severity:T27
A1	CUI E1 C0271650
A2	UMLS-Preferred-Name E1 Impaired glucose tolerance
A3	MEDDRA-PT E1 Glucose tolerance impaired
A4	MEDDRA-PT-ID E1 10018429
A5	LLT E1 Glucose intolerance
A6	LLT-ID E1 10052426
A7	CUI E5 C0020517
A8	UMLS-Preferred-Name E5 Hypersensitivity
A9	MEDDRA-PT E5 Hypersensitivity
A10	MEDDRA-PT-ID E5 10020751
A11	LLT E5 Hypersensitivity reaction
A12	LLT-ID E5 10020756
A13	CUI E8 C0030305
A14	UMLS-Preferred-Name E8 Pancreatitis
A15	MEDDRA-PT E8 Pancreatitis
A16	MEDDRA-PT-ID E8 10033645
A17	CUI E9 C0271650
A18	UMLS-Preferred-Name E9 Impaired glucose tolerance
A19	MEDDRA-PT E9 Glucose tolerance impaired
A20	MEDDRA-PT-ID E9 10018429
A21	LLT E9 Glucose intolerance
A22	LLT-ID E9 10052426
A23	CUI E10 C0271650
A24	UMLS-Preferred-Name E10 Impaired glucose tolerance
A25	MEDDRA-PT E10 Glucose tolerance impaired
A26	MEDDRA-PT-ID E10 10018429
A27	LLT E10 Glucose intolerance
A28	LLT-ID E10 10052426
A29	CUI E13 C0040053
A30	UMLS-Preferred-Name E13 Thrombosis
A31	MEDDRA-PT E13 Thrombosis
A32	MEDDRA-PT-ID E13 10043607
A33	CUI E15 C0338575
A34	UMLS-Preferred-Name E15 Sagittal Sinus Thrombosis
A35	MEDDRA-PT E15 Superior sagittal sinus thrombosis
A36	MEDDRA-PT-ID E15 10042567
A37	LLT E15 Sagittal sinus thrombosis
A38	LLT-ID E15 10039369
A39	CUI E16 C0034065
A40	UMLS-Preferred-Name E16 Pulmonary Embolism
A41	MEDDRA-PT E16 Pulmonary embolism
A42	MEDDRA-PT-ID E16 10037377
A43	CUI E17 C0272315
A44	UMLS-Preferred-Name E17 Coagulation factor deficiency syndrome
A45	MEDDRA-PT E17 Coagulation factor decreased
A46	MEDDRA-PT-ID E17 10009736
A47	CUI E18 C1295715
A48	UMLS-Preferred-Name E18 Decreased fibrinogen
A49	MEDDRA-PT E18 Blood fibrinogen decreased
A50	MEDDRA-PT-ID E18 10005520
A51	LLT E18 Fibrinogen decreased
A52	LLT-ID E18 10016596
A53	CUI E19 C0852955
A54	UMLS-Preferred-Name E19 Protein C decreased
A55	MEDDRA-PT E19 Protein C decreased
A56	MEDDRA-PT-ID E19 10037005
A57	CUI E20 C0919888
A58	UMLS-Preferred-Name E20 Protein S decreased
A59	MEDDRA-PT E20 Protein S decreased
A60	MEDDRA-PT-ID E20 10051120
A61	CUI E21 C0238665
A62	UMLS-Preferred-Name E21 Antithrombin III decreased
A63	MEDDRA-PT E21 Antithrombin III decreased
A64	MEDDRA-PT-ID E21 10049547
A65	CUI E22 C0040053
A66	UMLS-Preferred-Name E22 Thrombosis
A67	MEDDRA-PT E22 Thrombosis
A68	MEDDRA-PT-ID E22 10043607
A69	CUI E23 C0019080
A70	UMLS-Preferred-Name E23 Hemorrhage
A71	MEDDRA-PT E23 Haemorrhage
A72	MEDDRA-PT-ID E23 10055798
A73	LLT E23 Hemorrhage
A74	LLT-ID E23 10019524
A75	CUI E24 C0020517
A76	UMLS-Preferred-Name E24 Hypersensitivity
A77	MEDDRA-PT E24 Hypersensitivity
A78	MEDDRA-PT-ID E24 10020751
A79	LLT E24 Hypersensitivity reaction
A80	LLT-ID E24 10020756
A81	CUI E26 C0002792
A82	UMLS-Preferred-Name E26 anaphylaxis
A83	MEDDRA-PT E26 Anaphylactic reaction
A84	MEDDRA-PT-ID E26 10002198
A85	LLT E26 Anaphylaxis
A86	LLT-ID E26 10002218
A87	CUI E27 C0267940
A88	UMLS-Preferred-Name E27 Acute hemorrhagic pancreatitis
A89	MEDDRA-PT E27 Pancreatitis haemorrhagic
A90	MEDDRA-PT-ID E27 10033650
A91	LLT E27 Hemorrhagic pancreatitis
A92	LLT-ID E27 10019607
A93	CUI E28 C0030305
A94	UMLS-Preferred-Name E28 Pancreatitis
A95	MEDDRA-PT E28 Pancreatitis
A96	MEDDRA-PT-ID E28 10033645
